Cargando…

Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis

BACKGROUND: Postmenopausal osteoporosis (PMO) is influenced by estrogen metabolism and immune response, which are modulated by several factors including the microbiome and inflammation. Therefore, there is increasing interest in understanding the role of microbiota in PMO. OBJECTIVES: To investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xueli, Chang, Tian, Yuan, Qian, Wei, Wei, Wang, Pingping, Song, Xiaojian, Yuan, Huijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411790/
https://www.ncbi.nlm.nih.gov/pubmed/36032115
http://dx.doi.org/10.3389/fimmu.2022.930244
_version_ 1784775342642167808
author Yang, Xueli
Chang, Tian
Yuan, Qian
Wei, Wei
Wang, Pingping
Song, Xiaojian
Yuan, Huijuan
author_facet Yang, Xueli
Chang, Tian
Yuan, Qian
Wei, Wei
Wang, Pingping
Song, Xiaojian
Yuan, Huijuan
author_sort Yang, Xueli
collection PubMed
description BACKGROUND: Postmenopausal osteoporosis (PMO) is influenced by estrogen metabolism and immune response, which are modulated by several factors including the microbiome and inflammation. Therefore, there is increasing interest in understanding the role of microbiota in PMO. OBJECTIVES: To investigate variations in gut microbiota (GM) and vaginal microbiota (VM) in postmenopausal women with osteoporosis. METHODS: A total of 132 postmenopausal women were recruited for the study and divided into osteoporosis (n = 34), osteopenia (n = 47), and control (n = 51) groups based on their T score. The serum levels of interleukin (IL)-10, tumor necrosis factor (TNF)-α, and lipopolysaccharide-binding protein were determined via enzyme-linked immunosorbent assay. Additionally, 16S rRNA gene V3-V4 region sequencing was performed to investigate the GM and VM of the participants. RESULTS: Significant differences were observed in the microbial compositions of fecal and vaginal samples between groups (p < 0.05). It was noted that for GM, Romboutsia, unclassified_Mollicutes, and Weissella spp. were enriched in the control group, whereas the abundances of Fusicatenibacter, Lachnoclostridium, and Megamonas spp. were higher in the osteoporosis group than in the other groups. Additionally, for VM, Lactobacillus was enriched in the control group, whereas the abundances of Peptoniphilus, Propionimicrobium, and Gallicola spp. were higher in the osteoporosis group than in the other groups. The predicted functional capacities of GM and VM were different in the various groups. We also found that the serum level of IL-10 in the osteoporosis group was significantly lower than that in the control group and osteopenia group, while TNF-α was significantly higher in the osteoporosis group than that in the control group (p < 0.05). CONCLUSION: The results show that changes in BMD in postmenopausal women are associated with the changes in GM and VM; however, changes in GM are more closely correlated with PMO than VM.
format Online
Article
Text
id pubmed-9411790
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94117902022-08-27 Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis Yang, Xueli Chang, Tian Yuan, Qian Wei, Wei Wang, Pingping Song, Xiaojian Yuan, Huijuan Front Immunol Immunology BACKGROUND: Postmenopausal osteoporosis (PMO) is influenced by estrogen metabolism and immune response, which are modulated by several factors including the microbiome and inflammation. Therefore, there is increasing interest in understanding the role of microbiota in PMO. OBJECTIVES: To investigate variations in gut microbiota (GM) and vaginal microbiota (VM) in postmenopausal women with osteoporosis. METHODS: A total of 132 postmenopausal women were recruited for the study and divided into osteoporosis (n = 34), osteopenia (n = 47), and control (n = 51) groups based on their T score. The serum levels of interleukin (IL)-10, tumor necrosis factor (TNF)-α, and lipopolysaccharide-binding protein were determined via enzyme-linked immunosorbent assay. Additionally, 16S rRNA gene V3-V4 region sequencing was performed to investigate the GM and VM of the participants. RESULTS: Significant differences were observed in the microbial compositions of fecal and vaginal samples between groups (p < 0.05). It was noted that for GM, Romboutsia, unclassified_Mollicutes, and Weissella spp. were enriched in the control group, whereas the abundances of Fusicatenibacter, Lachnoclostridium, and Megamonas spp. were higher in the osteoporosis group than in the other groups. Additionally, for VM, Lactobacillus was enriched in the control group, whereas the abundances of Peptoniphilus, Propionimicrobium, and Gallicola spp. were higher in the osteoporosis group than in the other groups. The predicted functional capacities of GM and VM were different in the various groups. We also found that the serum level of IL-10 in the osteoporosis group was significantly lower than that in the control group and osteopenia group, while TNF-α was significantly higher in the osteoporosis group than that in the control group (p < 0.05). CONCLUSION: The results show that changes in BMD in postmenopausal women are associated with the changes in GM and VM; however, changes in GM are more closely correlated with PMO than VM. Frontiers Media S.A. 2022-08-12 /pmc/articles/PMC9411790/ /pubmed/36032115 http://dx.doi.org/10.3389/fimmu.2022.930244 Text en Copyright © 2022 Yang, Chang, Yuan, Wei, Wang, Song and Yuan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Yang, Xueli
Chang, Tian
Yuan, Qian
Wei, Wei
Wang, Pingping
Song, Xiaojian
Yuan, Huijuan
Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis
title Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis
title_full Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis
title_fullStr Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis
title_full_unstemmed Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis
title_short Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis
title_sort changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411790/
https://www.ncbi.nlm.nih.gov/pubmed/36032115
http://dx.doi.org/10.3389/fimmu.2022.930244
work_keys_str_mv AT yangxueli changesinthecompositionofgutandvaginalmicrobiotainpatientswithpostmenopausalosteoporosis
AT changtian changesinthecompositionofgutandvaginalmicrobiotainpatientswithpostmenopausalosteoporosis
AT yuanqian changesinthecompositionofgutandvaginalmicrobiotainpatientswithpostmenopausalosteoporosis
AT weiwei changesinthecompositionofgutandvaginalmicrobiotainpatientswithpostmenopausalosteoporosis
AT wangpingping changesinthecompositionofgutandvaginalmicrobiotainpatientswithpostmenopausalosteoporosis
AT songxiaojian changesinthecompositionofgutandvaginalmicrobiotainpatientswithpostmenopausalosteoporosis
AT yuanhuijuan changesinthecompositionofgutandvaginalmicrobiotainpatientswithpostmenopausalosteoporosis